Mark Schoenberg

Chief Medical Officer

Mark Schoenberg (Chief Medical Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in UroGen Pharma Ltd. (URGN). The largest single filing was $2.9M of URGN (60,677 sh × $47.05, as filed), executed Aug 20.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.3M

shares × price, as filed

Last traded

Aug 20

Filed Aug 24

Median ADV $38.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

URGN

UroGen Pharma Ltd. URGN · 0 buys · 7 sells 7 filings

Recent filings

URGNSALE UroGen Pharma Ltd. View filing → $2.9M
60,677 sh × $47.05
Exec Aug 20
Filed Aug 24 · 5:03 PM ET URGNSALE UroGen Pharma Ltd. View filing → $400K
10,000 sh × $40.00
Exec Jul 9
Filed Jul 10 · 2:17 PM ET URGNSALE UroGen Pharma Ltd. View filing → $350K
10,000 sh × $35.01
Exec Jun 22
Filed Jun 24 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. View filing → $143K
5,222 sh × $27.30
Exec Jun 8
Filed Jun 9 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. View filing → $300K
10,000 sh × $30.00
Exec May 8
Filed May 11 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. View filing → $250K
10,000 sh × $25.00
Exec Nov 19 2025
Filed Nov 20 2025 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. View filing → $177K
10,000 sh × $17.69
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET